Sradha S. Kotwal
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 04, 2026
Sex disparities in receiving evidence-based medications in patients with CKD.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 19, 2026
ISN International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic (CKM) Health.
ISN International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic (CKM) Health.
Journal: Kidney international
Published: March 27, 2026
Comparing Catheters with Fistulas in Older Patients Starting Hemodialysis: A Pilot Randomized Controlled Trial.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 09, 2026
Efficacy and Safety of Atrasentan in Patients with IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors: Placebo-Controlled, Crossover Trial.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 06, 2026
Advances in understanding the impact of sex on kidney health and disease.
Journal: Lancet (London, England)
Published: December 16, 2025
Efficacy and Safety of Simultaneous Initiation of SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease or Heart Failure: A Systematic Review and Meta-Analysis.
Journal: JACC. Heart failure
Published: December 12, 2025
A scoping review of specialist hypertension clinics.
Journal: Internal medicine journal
Published: December 03, 2025
Sodium-glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes and Chronic Kidney Disease Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20 mL/min/1.73 m2.
Journal: Journal of cardiac failure
Published: December 01, 2025
SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2.
Journal: Journal of cardiac failure
Published: December 01, 2025
Last Updated: 09/26/2026